TARPLIN, DOWNS & YOUNG, LLC

Lobbying for IDORSIA PHARMACEUTICALS US INC · Biopharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Pennsylvania · House · Senate · $50,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

policies related to the regulation of and access to insomnia treatments

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.